MarketInOut Stock Screener Log In | Sign Up
 

INmune Bio Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
INmune Bio Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization40.52 mln
Float24.75 mln
Earnings Date11/04/2026

Piotroski F-Score

2 / 9
Weak

Relative Strength

10 / 100
Significantly lagging

Debt / Equity

0.07
Debt-free

ROE

-77.66
Deeply negative

ROA

-58.70
Deeply negative

Business Description

INmune Bio is a US-based clinical-stage company developing treatments that work by retraining the body's immune system to fight disease. Its pipeline includes therapies targeting blood cancers, solid tumors, chronic inflammation, Alzheimer's disease, and treatment-resistant depression. Founded in 2015 and headquartered in Boca Raton, Florida, the company works alongside several academic and industry partners to advance its drug candidates through clinical trials.

Key Fundamentals

EPS-0.67
ROE-77.66
ROIC-594
ROA-58.70
EBITDA, mln-18.21
EV / EBITDA-1.94
EV / EBIT-1.92
Revenue, mln0.05
EV / Revenue706

Quote Details

Last 1.46
Change -0.08 (-5.19%)
Open 1.53
Volume 190,559
Turnover 278,216
Average Volume 276,262

Financial Ratios

Leverage Ratio1.32
Current Ratio4.04
Price / Book2.52
Price / Tangible Book2.52
Debt / Equity0.07
Price / Sales970

Financial Strength

Piotroski F-Score 2 / 9
Short Ratio7.85
Short % of Float10.72

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -7.01% 13 / 100   
1 Month -27% 13 / 100   
2 Months -26.63% 18 / 100   
6 Months 5.04% 72 / 100   
1 Year -17.98% 31 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog